Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells

Genes and Development

Volumn 17, Issue 7, 2003, Pages 832-837

  Jiang, Ming ^a   Milner, Jo ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Apoptosis; Bax; Bcl 2; Bcl xl; Colorectal cancer; p53

Indexed keywords

ISOPROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASE 2; CASPASES; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; GENES, P53; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 0037380598     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.252603     Document Type: Article

References (20)

1. Boise, L.H., Gonzalez-Garcia, M., Posterna, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G., and Thompson, C.B. 1993. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
2. Branch, P., Hampson, R., and Karran, P. 1995. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotype in human colorectal carcinoma cell lines. Cancer Res. 55: 2304-2309.
3. Bunz, F., Hwang, P.M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K.W., and Vogelstein, B. 1999. Disruption of p53 in human cancer cells alters the responses to chemotherapeutic agents. J. Clin. Invest. 104: 263-269.
4. Cory, S. and Adams, J.M. 2002. The Bcl2 family: Regulators of the cell life-or-death switch. Nat. Rev. Cancer 2: 647-656.
5. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 441: 494-498.
6. He, T.C., Chan, T.A., Vogelstein, B., and Kinzler, K.W. 1999. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345.
7. Hood, J.D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R.A., Xiang, R., and Cheresh, D.A. 2000. Tumor regression by targeted gene delivery to the neovasculature. Science 296: 2404-2407.
8. Ionov, Y., Peinado, M.A., Malkhosyan, S., Shibita, D., and Perucho, M. 1993. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colon carcinogenesis. Nature 363: 558-561.
9. Ionov, Y., Yamamoto, H., Krajewski, S., Reed, J.C., and Perucho, M. 2000. Mutational inactivation of the proapoptotic gene Bax confers selective advantage during tumour clonal evolution. Proc. Natl. Acad. Sci. 97: 10872-10877.
10. Jiang, M. and Milner, J. 2002. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21: 6041-6048.
11. Johnstone, R.W., Ruefli, A.A., and Lowe, S.W. 2002. Apoptosis: A link between cancer genetics and chemotherapy. Cell 108: 153-164.
12. Lassus, P., Optiz-Araya, X., and Lazebnik, Y. 2002. Requirement for caspase 2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297: 1352-1354.
13. LeBlanc, H., Lawrence, D., Varfolomeev, E., Totpal, K., Morlan, J., Schow, P., Fong, S., Schwall, R., Sinicropi, D., and Ashkenazi, A. 2002. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homologue Bax. Nat. Med. 8: 274-281.
14. Lynch, H.T. 1999. Hereditary nonpolyposis colorectal cancer (HNPCRC). Cytogenet. Cell Genet. 86: 130-135.
15. Marsden, V.S., O'Connor, L., O'Reilly, L.A., Silke, J., Metcalf, D., Ekert, P.G., Huang, D.C., Cecconi, F., Kuida, K., Tomaselli, K.J., et al. 2002. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase 9 apoptosome. Nature 419: 634-637.
16. Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J.C., and Perucho, M. 1997. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969.
17. Reed, J.C. 2002. Apoptosis-based therapies. Nat. Rev. Drug Discov. 1: 111-121.
18. Strasser, A., Harris, A.W., Jacks, T., and Cory, S. 1994. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by BCL-2. Cell 79: 329-339.
19. Yamamoto, Y., Yin, M.J., Lin, K.M., and Gaynor, R.B. 1999. Sulindac inhibits activation of the NF-κB pathway. J. Biol. Chem. 274: 27307-27314.
20. Zhang, L., Yu, J., Park, B.H., Knizler, K.W., and Vogelstein, B. 2000. Role of BAX in the apoptotic response to anticancer agents. Science 290: 989-992.